RA Capital Management’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-4,858,260
| Closed | -$233M | – | 66 |
|
|
2020
Q1 | $233M | Hold |
4,858,260
| – | – | 7.37% | 2 |
|
|
2019
Q4 | $228M | Hold |
4,858,260
| – | – | 6.91% | 3 |
|
|
2019
Q3 | $115M | Hold |
4,858,260
| – | – | 6.85% | 4 |
|
|
2019
Q2 | $137M | Hold |
4,858,260
| – | – | 7.35% | 4 |
|
|
2019
Q1 | $109M | Hold |
4,858,260
| – | – | 4.69% | 5 |
|
|
2018
Q4 | $34M | Buy |
4,858,260
+1,006,452
| +26% | +$15.8M | 1.98% | 15 |
|
|
2018
Q3 | $69.7M | Hold |
3,851,808
| – | – | 3.73% | 8 |
|
|
2018
Q2 | $38.3M | Hold |
3,851,808
| – | – | 2.49% | 16 |
|
|
2018
Q1 | $20.5M | Buy |
3,851,808
+2,500,000
| +185% | +$17.9M | 1.57% | 14 |
|
|
2017
Q4 | $11.5M | Hold |
1,351,808
| – | – | 0.96% | 19 |
|
|
2017
Q3 | $19.7M | Hold |
1,351,808
| – | – | 1.78% | 17 |
|
|
2017
Q2 | $25.3M | Hold |
1,351,808
| – | – | 2.91% | 11 |
|
|
2017
Q1 | $28.8M | Hold |
1,351,808
| – | – | 3.53% | 7 |
|
|
2016
Q4 | $20.5M | Buy |
+1,351,808
| New | +$18.4M | 2.91% | 8 |
|
